IP Library Granted Patent US 9,757,152
Granted Patent B2
US 9,757,152 · App. 15/488,870 · Granted Sep 12, 2017

Method of treating scoliosis using a biological implant

Inventors: James W. Ogilvie (Brighton, UT); Kenneth Ward (Salt Lake City, UT); Lesa M. Nelson (Park City, UT)
A61B17/56A61B17/70A61L27/54A61L27/58A61B2017/00004A61B2017/00893A61B2017/564A61L2300/414A61L2300/416A61L2300/43A61L2300/45A61L2300/604A61L2430/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,757,152
App. No.
15/488,870
Granted
Sep 12, 2017
Kind
B2
Abstract

The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.

Claims (21)

1. A method comprising applying a spine deformation therapeutic to a patient having a spine deformation altered risk associated biological marker.

2. The method of claim 1 , wherein said spine deformation altered risk associated biological marker defines the minor allele of a SNP.

3. The method of claim 1 , wherein said spine deformation therapeutic defines at least one of implanting a biological implant into said patient, performing spinal surgery on said patient, applying a brace to said patient, continuing the use of a brace on said patient, taking a spinal X-ray of said patient, continuing ongoing periodic spinal X-rays of said patient, and monitoring spine curve progression of said patient.

4. The method of claim 3 , wherein said biological implant defines at least one of a dissolvable bone growth stimulant coated with a dissolvable coating and a dissolvable bone growth inhibitor coated with a dissolvable coating.

5. The method of claim 4 , wherein said bone growth stimulant comprises at least one of a Parathyroid hormone, a Fibroblast growth factor, an androgen, an Insulin-like Growth Factor, an Estrogen, a Transforming Growth Factor, and an inorganic phosphate, and wherein said bone growth inhibitor comprises methotrexate.

6. The method of claim 3 , wherein said biological implant defines at least one bone growth promoting implant and at least one bone growth inhibiting implant, and wherein said spine includes a curve formed therein, and wherein said at least one bone growth promoting implant is inserted proximate a concave side of said curve of said spine, and wherein said at least one bone growth inhibiting implant is inserted proximate a convex side of said curve of said spine.

7. The method of claim 3 , wherein said spinal surgery defines joining at least one mechanical implant to a first vertebra and to a second vertebra of the spine of said patient, and wherein said brace defines an external brace for scoliosis therapy comprising: a rod having a first end and a second end; an auxiliary pad connected to said rod proximate said first end of said rod; a pelvic mold connected to said rod proximate said second end of said rod; a mechanical adjustment mechanism coupled to said rod between said first end of said rod and said second end of said rod, and an apical pad connected to said adjustment mechanism.

8. A method comprising applying a spine non-deformation therapeutic to a patient having a spine deformation altered risk associated biological marker.

9. The method of claim 8 , wherein said spine deformation altered risk associated biological marker defines the minor allele of a SNP.

10. The method of claim 8 , wherein said spine non-deformation therapeutic defines at least one of the cancelation of a contemplated implantation of a biological implant into said patient, the cancelation of contemplated spinal surgery of said patient, the prevention of the application of a brace to said patient, the cancelation of continued use of a brace on said patient, the prevention of the taking of a spinal X-ray of said patient, the cancelation of ongoing periodic spinal X-rays of said patient, and the cancelation of monitoring of spine curve progression of said patient.

11. The method of claim 10 , wherein said biological implant defines at least one of a dissolvable bone growth stimulant coated with a dissolvable coating and a dissolvable bone growth inhibitor coated with a dissolvable coating.

12. The method of claim 11 , wherein said bone growth stimulant comprises at least one of a Parathyroid hormone, a Fibroblast growth factor, an androgen, an Insulin-like Growth Factor, an Estrogen, a Transforming Growth Factor, and an inorganic phosphate, and wherein said bone growth inhibitor comprises methotrexate.

13. The method of claim 10 , wherein said biological implant defines at least one bone growth promoting implant and at least one bone growth inhibiting implant, and wherein said spine includes a curve formed therein, and wherein said at least one bone growth promoting implant is inserted proximate a concave side of said curve of said spine, and wherein said at least one bone growth inhibiting implant is inserted proximate a convex side of said curve of said spine.

14. The method of claim 10 , wherein said spinal surgery defines joining at least one mechanical implant to a first vertebra and to a second vertebra of the spine of said patient, and wherein said brace defines an external brace for scoliosis therapy comprising: a rod having a first end and a second end; an auxiliary pad connected to said rod proximate said first end of said rod; a pelvic mold connected to said rod proximate said second end of said rod; a mechanical adjustment mechanism coupled to said rod between said first end of said rod and said second end of said rod, and an apical pad connected to said adjustment mechanism.

15. A method comprising applying at least one of a spine deformation therapeutic and a spine non-deformation therapeutic to a patient having at least one spine deformation altered risk associated biological marker.

16. The method of claim 15 , wherein said spine deformation altered risk associated biological marker defines the minor allele of a SNP.

17. The method of claim 15 , wherein said spine deformation therapeutic defines at least one of implanting a biological implant into said patient, performing spinal surgery on said patient, applying a brace to said patient, continuing the use of a brace on said patient, taking a spinal X-ray of said patient, continuing ongoing periodic spinal X-rays of said patient, and monitoring spine curve progression of said patient, and wherein said spine non-deformation therapeutic defines at least one of the cancelation of a contemplated implantation of a biological implant into said patient, the cancelation of contemplated spinal surgery of said patient, the prevention of the application of a brace to said patient, the cancelation of continued use of a brace on said patient, the prevention of the taking of a spinal X-ray of said patient, the cancelation of ongoing periodic spinal X-rays of said patient, and the cancelation of monitoring of spine curve progression of said patient.

18. The method of claim 17 , wherein said biological implant defines at least one of a dissolvable bone growth stimulant coated with a dissolvable coating and a dissolvable bone growth inhibitor coated with a dissolvable coating.

19. The method of claim 18 , wherein said bone growth stimulant comprises at least one of a Parathyroid hormone, a Fibroblast growth factor, an androgen, an Insulin-like Growth Factor, an Estrogen, a Transforming Growth Factor, and an inorganic phosphate, and wherein said bone growth inhibitor comprises methotrexate.

20. The method of claim 17 , wherein said biological implant defines at least one bone growth promoting implant and at least one bone growth inhibiting implant, and wherein said spine includes a curve formed therein, and wherein said at least one bone growth promoting implant is inserted proximate a concave side of said curve of said spine, and wherein said at least one bone growth inhibiting implant is inserted proximate a convex side of said curve of said spine.

21. The method of claim 17 , wherein said spinal surgery defines joining at least one mechanical implant to a first vertebra and to a second vertebra of the spine of said patient, and wherein said brace defines an external brace for scoliosis therapy comprising: a rod having a first end and a second end; an auxiliary pad connected to said rod proximate said first end of said rod; a pelvic mold connected to said rod proximate said second end of said rod; a mechanical adjustment mechanism coupled to said rod between said first end of said rod and said second end of said rod, and an apical pad connected to said adjustment mechanism.

Assignments (5)
SECURITY INTEREST Recorded Nov 13, 2024
From: PREDICTIVE TECHNOLOGY GROUP, INC.
To: TYUMEN HOLDINGS, LLC
Reel/Frame 069249/0433 →
SECURITY INTEREST Recorded Nov 13, 2024
From: PREDICTIVE TECHNOLOGY GROUP, INC.
To: TYUMEN HOLDINGS, LLC
Reel/Frame 069249/0506 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: SCHRAMM, MICHAEL R.
To: PREDICTIVE TECHNOLOGY GROUP, INC.
Reel/Frame 044700/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2018
From: SCHRAMM, MICHAEL R.
To: PREDICTIVE THERAPEUTICS, LLC
Reel/Frame 044666/0421 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2017
From: OGILVIE, JAMES W.; WARD, KENNETH; NELSON, LESA M.; AXIAL BIOTECH, INC.
To: SCHRAMM, MICHAEL R.
Reel/Frame 042028/0773 →
Continuity (13)
Continuation 15186914 · Jun 20, 2016
Continuation 14170691 · Feb 3, 2014
Continuation In Part 13357800 · Jan 25, 2012
Continuation In Part 12341289 · Dec 22, 2008
Continuation In Part 11259941 · Oct 26, 2005
Continuation In Part 11968046 · Dec 31, 2007
Continuation PCTUS2007072785 · Jul 3, 2007
Provisional Application 61073119 · Jun 17, 2008
Provisional Application 61082503 · Jul 21, 2008
Provisional Application 60622999 · Oct 28, 2004
Provisional Application 60806498 · Jul 3, 2006
Provisional Application 60825260 · Sep 11, 2006
Related Publication 20170215921A1 · Aug 3, 2017